// App-Quantinova.ai

P738 : Assessing aCCess to investigations in IBD (ACCID) – results from an international inflammatory bowel disease survey

Researchers

Presenter

  • N.S. Ding

Principal Investigators

  • B. Yazdanian

  • D. Bettenworth

  • I. Cleynen

  • N.A. Yassin

  • A. Armuzzi

  • M. Ferrante

  • E.S. Zagorowicz

  • J. Mansfield

  • J. Gisbert

  • T. Raine

Medical Centers

  • St Vincent's Hospital, Inflammatory Bowel Disease, Melbourne, Australia

  • St Mark's Hospital, Inflammatory Bowel Disease Unit, London, United Kingdom

  • Imperial College London, Department of Surgery and Cancer, London, United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Univ. Hospital Munster, Department of Medicine A, Muenster, Germany

  • KU Leuven, Leuven, Belgium

  • Complesso Integrato Columbus Gastroenterology Unit Via Moscati 31, 167 Rome, Italy, Rome, Italy

  • UZ Leuven Department of Gastroenterology Herestraat 49, 3000, Leuven, Belgium

  • The Maria Sklodowska Curie Memorial Cancer Centre and Institute of Oncology Department of Gastroenterology ul. W.K. Roentgena 5, 02–781, Warsaw, Poland

  • Royal Victoria Infirmary Department of Gastroenterology Queen Victoria Road, Newcastle Upon Tyne, United Kingdom

  • Hospital Universitario de La Princesa Department of Gastroenterology Calle de Diego Leon, 62, Madrid, Spain

Locations

  • Australia

  • United Kingdom

  • Germany

  • Belgium

  • Italy

  • Poland

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A